| BE0373-100MG
| InVivoMAb anti-mouse osteopontin (SPP1)
| 100 mg
| BioXCell
| in vivo OPN neutralization, in vitro OPN neutraliz
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0334-1MG
| InVivoMAb anti-mouse NKG2D (CD314)
| 1 mg
| BioXCell
| in vivo NKG2D blockade, in vitro NKG2D blockade, F
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0336-50MG
| InVivoMAb anti-human MUC1 (CD227)
| 50 mg
| BioXCell
| in vivo administration in mouse xenograft models,
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0335-1MG
| InVivoMAb anti-human MAGE-C2 (CT10)
| 1 mg
| BioXCell
| Immunohistochemistry (paraffin), Immunofluorescenc
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0371-100MG
| InVivoMAb anti-mouse IL-12 p35
| 100 mg
| BioXCell
| in vivo IL-12 p35 neutralization, in vitro IL-12 p
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0342-25MG
| InVivoMAb recombinant Flt-3L-Ig (hum/hum)
| 25 mg
| BioXCell
|
|
|
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0306-1MG
| InVivoMAb anti-human/monkey MHC class II (HLA-DR)
| 1 mg
| BioXCell
| in vitro blocking of MHC class II HLA-DR, HLA clas
|
| Mouse
| Human, Monkey
| Solicitar Precio
| Solicitar
|
| BE0330-25MG
| InVivoMAb anti-mouse CD69
| 25 mg
| BioXCell
| in vivo down-regulation of CD69 expression, Functi
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0340-100MG
| InVivoMAb anti-human/monkey MDR-1 (CD243)
| 100 mg
| BioXCell
| in vivo MDR-1 blocking/depletion in xenogeneic mur
|
| Mouse
| Human, Monkey
| Solicitar Precio
| Solicitar
|
| BE0348-1MG
| InVivoMAb anti-mouse CD27
| 1 mg
| BioXCell
| in vivo CD27 stimulation, in vitro CD27 stimulatio
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0339-25MG
| InVivoMAb anti-mouse NKG2AB6
| 25 mg
| BioXCell
| Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0310-5MG
| InVivoMAb anti-mouse VISTA
| 5 mg
| BioXCell
| in vivo blocking of VISTA signaling, in vitro bloc
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0315-50MG
| InVivoMAb anti-mouse IL-15
| 50 mg
| BioXCell
| in vivo IL-15 neutralization, in vitro IL-15 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0341-5MG
| InVivoMAb anti-human EphA2
| 5 mg
| BioXCell
| Immunohistochemistry (paraffin), Immunoprecipitati
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0322-25MG
| InVivoMAb anti-mouse CD172a (SIRP?)
| 25 mg
| BioXCell
| in vivo SIRP? blocking, In vitro SIRP? blocking, W
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0305-100MG
| InVivoMAb anti-mouse CLEC9A (CD370)
| 100 mg
| BioXCell
| in vivo CLEC9A blockade, in vivo Ag targeting to C
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0366-50MG
| InVivoMAb mouse IgG2c isotype control, anti-dengue virus
| 50 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BE0350-25MG
| InVivoMAb anti-mouse/human PrP (prion protein)
| 25 mg
| BioXCell
| in vivo PrP blocking, Western blot
|
| Mouse
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0314-25MG
| InVivoMAb anti-mouse TIM-1 (CD365)
| 25 mg
| BioXCell
| in vivo TIM-1 blockade, in vitro TIM-1 blockade
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0347-5MG
| InVivoMAb anti-human CSF1R (CD115)
| 5 mg
| BioXCell
| in vitro CSF1R neutralization, Immunohistochemistr
|
| Rat
| Human
| Solicitar Precio
| Solicitar
|
| BE0304-50MG
| InVivoMAb anti-mouse BTLA (CD272)
| 50 mg
| BioXCell
| in vivo BTLA+ B cell and CD4 T cell depletion*, Fl
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0325-50MG
| InVivoMAb anti-West Nile/dengue virus E protein
| 50 mg
| BioXCell
| Neutralization of WNV, Neutralization of DENV1,2,3
|
| Mouse
| Virus
| Solicitar Precio
| Solicitar
|
| BE0299-50MG
| InVivoMAb anti-mouse CD200 (OX2)
| 50 mg
| BioXCell
| in vivo CD200 blockade, in vitro CD200 blockade, I
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0324-50MG
| InVivoMAb anti-human/mouse denatured collagen type-I (RGD motif)
| 50 mg
| BioXCell
| Western blot, Immunofluorescence, in vivo administ
|
| Mouse
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0317-1MG
| InVivoMAb anti-mouse CD38
| 1 mg
| BioXCell
| in vivo CD38 stimulation, in vitro CD38 stimulatio
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0364-1MG
| InVivoMAb anti-mouse BTLA (CD272)
| 1 mg
| BioXCell
| in vivo BTLA blockade, Flow cytometry
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0301-100MG
| InVivoMAb human IgG2 isotype control
| 100 mg
| BioXCell
|
|
| Human
|
| Solicitar Precio
| Solicitar
|
| BE0312-25MG
| InVivoMAb anti-mouse IFN?
| 25 mg
| BioXCell
| in vivo IFN? neutralization, in vitro IFN? neutral
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0346-1MG
| InVivoMAb anti-mouse CD326 (EpCAM)
| 1 mg
| BioXCell
| Immunohistochemistry (frozen), Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0308-1MG
| InVivoMAb anti-rat CD4
| 1 mg
| BioXCell
| in vivo CD4+ T cell depletion, Flow cytometry
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
| BE0367-1MG
| InVivoMAb anti-human CD71 (TfR1)
| 1 mg
| BioXCell
| in vitro CD71 targeting, in vivo CD71 targeting, I
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0367-25MG
| InVivoMAb anti-human CD71 (TfR1)
| 25 mg
| BioXCell
| in vitro CD71 targeting, in vivo CD71 targeting, I
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0350-100MG
| InVivoMAb anti-mouse/human PrP (prion protein)
| 100 mg
| BioXCell
| in vivo PrP blocking, Western blot
|
| Mouse
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0301-5MG
| InVivoMAb human IgG2 isotype control
| 5 mg
| BioXCell
|
|
| Human
|
| Solicitar Precio
| Solicitar
|
| BE0334-50MG
| InVivoMAb anti-mouse NKG2D (CD314)
| 50 mg
| BioXCell
| in vivo NKG2D blockade, in vitro NKG2D blockade, F
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0320-100MG
| InVivoMAb anti-mouse Ly6G/Ly6C
| 100 mg
| BioXCell
| in vivo neutrophil depletion, Immunohistochemistry
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0314-5MG
| InVivoMAb anti-mouse TIM-1 (CD365)
| 5 mg
| BioXCell
| in vivo TIM-1 blockade, in vitro TIM-1 blockade
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0375-50MG
| InVivoMAb anti-human EGFR
| 50 mg
| BioXCell
| in vivo EGFR blockade in xenografts, in vitro EGFR
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0328-5MG
| InVivoMAb anti-mouse CD28
| 5 mg
| BioXCell
| in vivo T cell stimulation/activation, in vitro T
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0375-1MG
| InVivoMAb anti-human EGFR
| 1 mg
| BioXCell
| in vivo EGFR blockade in xenografts, in vitro EGFR
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0378-25MG
| InVivoMAb anti-mouse CD16.2 (Fc?RIV)
| 25 mg
| BioXCell
| in vivo CD16.2 blockade, in vitro CD16.2 blockade,
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0337-5MG
| InVivoMAb anti-mouse CD96
| 5 mg
| BioXCell
| in vivo CD96 blocking, in vitro CD96 blocking, Flo
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0356-100MG
| InVivoMAb anti-mouse CD20
| 100 mg
| BioXCell
| in vivo B cell depletion, Western blot
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0361-50MG
| InVivoMAb anti-mouse PD-L1 (B7-H1)
| 50 mg
| BioXCell
| in vivo blocking of PD-L1/CD80 (B7-1) interactions
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0354-25MG
| InVivoMAb anti-human CD2
| 25 mg
| BioXCell
| in vivo CD2 blockade in huCD2tg mice
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0338-25MG
| InVivoMAb anti-human CD220 (Insulin Receptor)
| 25 mg
| BioXCell
| Western blot
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0321-25MG
| InVivoMAb anti-mouse NKG2A/C/E
| 25 mg
| BioXCell
| in vivo NKG2A blockade (see description), in vitro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0330-50MG
| InVivoMAb anti-mouse CD69
| 50 mg
| BioXCell
| in vivo down-regulation of CD69 expression, Functi
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0312-1MG
| InVivoMAb anti-mouse IFN?
| 1 mg
| BioXCell
| in vivo IFN? neutralization, in vitro IFN? neutral
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0334-25MG
| InVivoMAb anti-mouse NKG2D (CD314)
| 25 mg
| BioXCell
| in vivo NKG2D blockade, in vitro NKG2D blockade, F
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|